Delivery Order SPE2DB22D1106-SPE2DB25FFAQ6
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 160 mg/16 ml vials, with a ceiling value of $6,528.00. This competitive, non-set-aside award was issued on June 25, 2025, with an ultimate completion date of June 26, 2025, and reflects a firm fixed-price arrangement. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/8 mL vials with a ceiling value of $1,314.60. This delivery order, issued on September 11, 2025, represents a firm fixed-price procurement executed without any set-aside designation, indicating competitive award to the contractor based on open competition. The product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,041.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Docetaxel 160 mg/16 ml vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive set-aside delivery order represents a pharmaceutical supply transaction fulfilling military healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- This is a $7,315.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 160 mg/16 ml vials of the cancer medication docetaxel. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,387.22, is for the supply of 4,564,688,768 mL of the pharmaceutical product Docetaxel 160 mg/16 mL. The order has a firm fixed-price pricing type and a completion date of May 23, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 160 mg/16 ml vials of the medication Docetaxel, a chemotherapy drug. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $3,916.80 and a period of performance through May 8, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Paclitaxel 300 mg/50 ml vials with a firm fixed price ceiling value of $1,126.20. This delivery order represents a non-set-aside, competitively awarded procurement supporting the federal government's pharmaceutical supply requirements. The award is fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...